A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Financial Difficulty in Patients With Blood Cancer
- Status
- COMPLETED
- Phase
- N/A
Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Prospective Evaluation of the Prognostic Impact of Measurable Residual Disease (MRD) Within a Phase III Study Comparing a Fixed Duration Therapy Versus Continuous Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma Requiring a First Salvage Treatment.
- Status
- RECRUITING
- Phase
- N/A
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- Status
- RECRUITING
- Phase
- PHASE4
Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
- Status
- RECRUITING
- Phase
- PHASE1
Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies
- Status
- TERMINATED
- Phase
- PHASE2
Early Integration of Palliative and Supportive Care in Cellular Therapy
- Status
- RECRUITING
- Phase
- NA
Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib
- Status
- UNKNOWN
- Phase
- NA
A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE4
FT576 in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Iberdomide Maintenance Therapy in Patients With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Perspectives of Subcutaneous Velcade at Home of Patients With Myeloma.
- Status
- COMPLETED
- Phase
- N/A
Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1
B Cell Maturation Antigen Targeted CAR-T Cells in Treatment With Relapsed and Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2